Evaluating the use of early transcranial ultrasound for diagnosing extrapyramidal diseases in Sweden
TRANSPARK_LONG: The Diagnostic Value of Early Transcranial Ultrasound in Patients With Extrapyramidal Diseases in a Swedish Population: an Evaluation in the Form of a Retrospective Cohort Study With a Long Follow-up Time
This study is testing if early ultrasound scans of the brain can help doctors better diagnose conditions like Parkinson's, essential tremor, and dementia in patients from Sweden.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Region Skane Academic / other |
| Locations | 1 site (Malmö, Skåne) |
| Trial ID | NCT06032585 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the diagnostic accuracy of early transcranial ultrasound findings in patients with parkinsonism, essential tremor, and dementia within a Swedish population. By reviewing medical records and conducting follow-up examinations, the researchers will determine how well initial ultrasound results correlate with final diagnoses after an extended follow-up period. Additionally, the study will explore changes in ultrasound findings over time and their potential links to cognitive decline or dementia development. The study focuses on patients who had satisfactory transcranial bone windows and were previously diagnosed before 2017.
Who should consider this trial
Good fit: Ideal candidates include patients with parkinsonism or essential tremor who had contact with the clinic before 2017 and possess a satisfactory transcranial bone window.
Not a fit: Patients without a transcranial bone window will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance diagnostic accuracy for patients with extrapyramidal diseases, leading to better-targeted treatments.
How similar studies have performed: While this approach is novel in the context of this specific population, previous studies have shown promise in using transcranial ultrasound for diagnosing similar conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with parkinsonism or essential tremor who came into contact with our clinic before 2017 * Satisfactory transcranial bone window * Previous TU (clinical indication) Exclusion Criteria: * No transcranial bone window
Where this trial is running
Malmö, Skåne
- Skåne Univ Hospital — Malmö, Skåne, Sweden (Recruiting)
Study contacts
- Study coordinator: Markus Stiehm
- Email: Markus.Stiehm@skane.se
- Phone: +4640336379
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.